Expert Commentary on the product profile of Belzutifan for Renal Cell Carcinoma
January 18th 2022In an interview with ONCOLOGY®, Natasha Khrystolubova, BPharm, RPh, BCOP, offers a comprehensive review of real-world treatment considerations of belzutifan as therapy for patients with renal cell carcinoma.